Mihaela Oprea
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mihaela Oprea has a total of 164 co-authors. Here are the top co-authors by number of shared publications:
- Sorin Dinu
Molecular Epidemiology for Communicable Diseases Laboratory, Cantacuzino National Military Medical Institute for Research and Development, Bucharest, Romania
7 shared publications - Codruţa-Romaniţa Usein
Cantacuzino National Medico-Military Institute for Research and Development
6 shared publications Daniela Cristea
Enteric Bacterial Infections Laboratory , “Cantacuzino” National Military Medical Institute for Research and Development , Bucharest , Romania
6 shared publicationsAdriana Simona Ciontea
Cantacuzino National Medico-Military Institute for Research and Development
4 shared publications- Codruta Romanita Usein
Cantacuzino National Military Medical Institute of Research and Development, 050096 Bucharest, Romania
4 shared publications - Laura-Ioana Popa
Genomics, Transcriptomics, and Bioinformatics Platform, Cantacuzino National Military Medical Institute for Research and Development, Romania
4 shared publications
Latest Publications
- Open Access
- 5 August 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (8) , 1716
Genomic Insights into the Population Structure and Antimicrobial Resistance of the Most Prevalent Human-Associated Non-Typhoidal Salmonella Serotypes in Romania
This study aimed to identify circulating lineages of the most prevalent human-associated Salmonella serotypes identified through routine surveillance in Romania between 2023 and 2025 and assess their role in the spread of antimicrobial resistance (AMR). A total of 271 isolates (217 S. Enteritidis, 28 monophasic S. Typhimurium, and 26 S. Typhimurium) were investigated using Illumina short-read sequencing. The isolates were assigned to 9 MLST sequence types (STs) and 109 core genome MLST complex types. The predominant STs were ST11 (96% in S. Enteritidis), ST19 (77% in S. Typhimurium), and ST34 (79% in monophasic S. Typhimurium). Overall, 148 isolates carried at least one AMR determinant, including 28 acquired genes and 6 gene mutations, conferring resistance to ten antimicrobial classes. Four percent of all isolates were predicted to be multidrug-resistant, often associated with determinants conferring tolerances to biocides and/or heavy metals. The most prevalent resistance markers were GyrA_D87Y in S. Enteritidis ST11 (94/217) and blaTEM-1 in S. Typhimurium ST19 (7/26). Among monophasic S. Typhimurium ST34 isolates, the co-occurrence of blaTEM-1, aph(3”)-Ib, aph(6)-Id, sul2, and tet(B) genes was common (17/28). The 43 predicted AMR plasmids were not shared across serotypes, except among those carrying the qnrB19 gene. These results provide a genomic baseline for AMR surveillance in Romania and strengthen the human surveillance component of national One Health efforts to control resistant Salmonella.
- 5 August 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (8) , 1716
Open AccessGenomic Insights into the Population Structure and Antimicrobial Resistance of the Most Prevalent Human-Associated Non-Typhoidal Salmonella Serotypes in Romania
This study aimed to identify circulating lineages of the most prevalent human-associated Salmonella serotypes identified through routine surveillance in Romania between 2023 and 2025 and assess their role in the spread of antimicrobial resistance (AMR). A total of 271 isolates (217 S. Enteritidis, 28 monophasic S. Typhimurium, and 26 S. Typhimurium) were investigated using Illumina short-read sequencing. The isolates were assigned to 9 MLST sequence types (STs) and 109 core genome MLST complex types. The predominant STs were ST11 (96% in S. Enteritidis), ST19 (77% in S. Typhimurium), and ST34 (79% in monophasic S. Typhimurium). Overall, 148 isolates carried at least one AMR determinant, including 28 acquired genes and 6 gene mutations, conferring resistance to ten antimicrobial classes. Four percent of all isolates were predicted to be multidrug-resistant, often associated with determinants conferring tolerances to biocides and/or heavy metals. The most prevalent resistance markers were GyrA_D87Y in S. Enteritidis ST11 (94/217) and blaTEM-1 in S. Typhimurium ST19 (7/26). Among monophasic S. Typhimurium ST34 isolates, the co-occurrence of blaTEM-1, aph(3”)-Ib, aph(6)-Id, sul2, and tet(B) genes was common (17/28). The 43 predicted AMR plasmids were not shared across serotypes, except among those carrying the qnrB19 gene. These results provide a genomic baseline for AMR surveillance in Romania and strengthen the human surveillance component of national One Health efforts to control resistant Salmonella.
- 4 March 2026
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 115 (3) , 117357
A case of Legionnaires’ disease linked to the household hot water system, confirmed by whole genome sequencing
- 4 March 2026
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 115 (3) , 117357
A case of Legionnaires’ disease linked to the household hot water system, confirmed by whole genome sequencing
- Open Access
Genomic and Clinical Profile of Hypervirulent Klebsiella pneumoniae (ST23-K1) Liver Abscesses: Experience with Patients at a Romanian University Hospital
Introduction: Hypervirulent Klebsiella pneumoniae (hvKp) is an emerging global pathogen that causes severe liver abscesses and metastatic infections. Despite rising concerns regarding multidrug-resistant convergence, molecular data in Romania remain limited. This study characterizes the epidemiological, clinical, and genomic profiles of hvKp liver abscesses in a tertiary hospital, aiming to describe the local virulence landscape and inform clinical management. Results: This study characterizes 15 cases of hvKp liver abscesses in a tertiary hospital. The cohort was predominantly male, with high rates of type 2 diabetes. Although clinical presentation was severe, featuring complications like endogenous endophthalmitis, the outcomes following prolonged antibiotic therapy were generally favorable. Phenotypically, 93.3% of isolates retained a wild-type susceptible profile, while a single ESBL-positive case highlighted the risk of resistance convergence. Genomic sequencing confirmed the presence of the ST23-K1 pandemic lineage carrying key virulence determinants (rmpA, iuc, and peg-344). Crucially, cgMLST analysis revealed genetic heterogeneity, suggesting sporadic community acquisition rather than a clonal nosocomial outbreak. Conclusions: These findings represent the first detailed molecular description of hvKp in Romania, confirming the local circulation of high-risk ST23 clones and underscoring the necessity for early detection and surveillance.
Open AccessGenomic and Clinical Profile of Hypervirulent Klebsiella pneumoniae (ST23-K1) Liver Abscesses: Experience with Patients at a Romanian University Hospital
Introduction: Hypervirulent Klebsiella pneumoniae (hvKp) is an emerging global pathogen that causes severe liver abscesses and metastatic infections. Despite rising concerns regarding multidrug-resistant convergence, molecular data in Romania remain limited. This study characterizes the epidemiological, clinical, and genomic profiles of hvKp liver abscesses in a tertiary hospital, aiming to describe the local virulence landscape and inform clinical management. Results: This study characterizes 15 cases of hvKp liver abscesses in a tertiary hospital. The cohort was predominantly male, with high rates of type 2 diabetes. Although clinical presentation was severe, featuring complications like endogenous endophthalmitis, the outcomes following prolonged antibiotic therapy were generally favorable. Phenotypically, 93.3% of isolates retained a wild-type susceptible profile, while a single ESBL-positive case highlighted the risk of resistance convergence. Genomic sequencing confirmed the presence of the ST23-K1 pandemic lineage carrying key virulence determinants (rmpA, iuc, and peg-344). Crucially, cgMLST analysis revealed genetic heterogeneity, suggesting sporadic community acquisition rather than a clonal nosocomial outbreak. Conclusions: These findings represent the first detailed molecular description of hvKp in Romania, confirming the local circulation of high-risk ST23 clones and underscoring the necessity for early detection and surveillance.
- Open Access
- 10 February 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (2) , 418
Molecular Characterization of Streptococcus pneumoniae Strains Isolated from Patients with Invasive Infections in a Romanian Hospital
Invasive pneumococcal disease (IPD) results from the dissemination of Streptococcus pneumoniae to normally sterile anatomical sites such as the bloodstream or cerebrospinal fluid. One of the primary roles of pneumococcal conjugate vaccines (PCVs) used in Romania is to reduce the burden of pneumococcal disease. This single-center retrospective study provides an updated overview of IPD epidemiology in a Romanian tertiary hospital. We analyzed 67 IPD cases identified between 2017 and 2023, of which 45 isolates underwent whole-genome sequencing followed by multilocus sequence typing. Results of genome sequence analysis revealed a diverse population of pneumococci, underlining the importance of continuous genomic surveillance. Expanded-valency pneumococcal conjugate vaccines (PCVs), particularly PCV20, showed markedly improved serotype coverage compared to PCV7 and PCV13, while PCV21 showed serotype coverage comparable to that of PCV13. Antimicrobial susceptibility testing revealed sustained resistance to beta-lactams, particularly among meningitis isolates, underscoring the need for targeted antibiotic stewardship and continuous monitoring of local resistance trends. Overall, these findings highlight the evolving epidemiology of invasive pneumococcal disease in Romania, in the post-PCV era, and the need to adapt vaccination and treatment strategies accordingly.
- 10 February 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (2) , 418
Open AccessMolecular Characterization of Streptococcus pneumoniae Strains Isolated from Patients with Invasive Infections in a Romanian Hospital
Invasive pneumococcal disease (IPD) results from the dissemination of Streptococcus pneumoniae to normally sterile anatomical sites such as the bloodstream or cerebrospinal fluid. One of the primary roles of pneumococcal conjugate vaccines (PCVs) used in Romania is to reduce the burden of pneumococcal disease. This single-center retrospective study provides an updated overview of IPD epidemiology in a Romanian tertiary hospital. We analyzed 67 IPD cases identified between 2017 and 2023, of which 45 isolates underwent whole-genome sequencing followed by multilocus sequence typing. Results of genome sequence analysis revealed a diverse population of pneumococci, underlining the importance of continuous genomic surveillance. Expanded-valency pneumococcal conjugate vaccines (PCVs), particularly PCV20, showed markedly improved serotype coverage compared to PCV7 and PCV13, while PCV21 showed serotype coverage comparable to that of PCV13. Antimicrobial susceptibility testing revealed sustained resistance to beta-lactams, particularly among meningitis isolates, underscoring the need for targeted antibiotic stewardship and continuous monitoring of local resistance trends. Overall, these findings highlight the evolving epidemiology of invasive pneumococcal disease in Romania, in the post-PCV era, and the need to adapt vaccination and treatment strategies accordingly.
- Open Access
- 19 July 2024
- Published by MDPI AG in Microorganisms
- Vol. 12 (7) , 1469
Shiga Toxin-Producing Escherichia coli Strains from Romania: A Whole Genome-Based Description
The zoonotic Shiga toxin-producing Escherichia coli (STEC) group is unanimously regarded as exceptionally hazardous for humans. This study aimed to provide a genomic perspective on the STEC recovered sporadically from humans and have a foundation of internationally comparable data. Fifty clinical STEC isolates, representing the culture-confirmed infections reported by the STEC Reference Laboratory between 2016 and 2023, were subjected to whole-genome sequencing (WGS) analysis and sequences were interpreted using both commercial and public free bioinformatics tools. The WGS analysis revealed a genetically diverse population of STEC dominated by non-O157 serogroups commonly reported in human STEC infections in the European Union. The O26:H11 strains of ST21 lineage played a major role in the clinical disease resulting in hospitalisation and cases of paediatric HUS in Romania surpassing the O157:H7 strains. The latter were all clade 7 and mostly ST1804. Notably, among the Romanian isolates was a stx2a-harbouring cryptic clade I strain associated with a HUS case, stx2f- and stx2e-positive strains, and hybrid strains displaying a mixture of intestinal and extraintestinal virulence genes were found. As a clearer picture emerges of the STEC strains responsible for infections in Romania, further surveillance efforts are needed to uncover their prevalence, sources, and reservoirs.
- 19 July 2024
- Published by MDPI AG in Microorganisms
- Vol. 12 (7) , 1469
Open AccessShiga Toxin-Producing Escherichia coli Strains from Romania: A Whole Genome-Based Description
The zoonotic Shiga toxin-producing Escherichia coli (STEC) group is unanimously regarded as exceptionally hazardous for humans. This study aimed to provide a genomic perspective on the STEC recovered sporadically from humans and have a foundation of internationally comparable data. Fifty clinical STEC isolates, representing the culture-confirmed infections reported by the STEC Reference Laboratory between 2016 and 2023, were subjected to whole-genome sequencing (WGS) analysis and sequences were interpreted using both commercial and public free bioinformatics tools. The WGS analysis revealed a genetically diverse population of STEC dominated by non-O157 serogroups commonly reported in human STEC infections in the European Union. The O26:H11 strains of ST21 lineage played a major role in the clinical disease resulting in hospitalisation and cases of paediatric HUS in Romania surpassing the O157:H7 strains. The latter were all clade 7 and mostly ST1804. Notably, among the Romanian isolates was a stx2a-harbouring cryptic clade I strain associated with a HUS case, stx2f- and stx2e-positive strains, and hybrid strains displaying a mixture of intestinal and extraintestinal virulence genes were found. As a clearer picture emerges of the STEC strains responsible for infections in Romania, further surveillance efforts are needed to uncover their prevalence, sources, and reservoirs.
- Open Access
- 16 March 2024
- Published by Elsevier in New Microbes and New Infections
- Vol. 58, 101239
Non-toxigenic Corynebacterium diphtheriae cutaneous infections among two injecting drug-users with HIV/Tuberculosis coinfection from Bucharest, Romania
- 16 March 2024
- Published by Elsevier in New Microbes and New Infections
- Vol. 58, 101239
Open AccessNon-toxigenic Corynebacterium diphtheriae cutaneous infections among two injecting drug-users with HIV/Tuberculosis coinfection from Bucharest, Romania
- Open Access
Sequencing and Partial Molecular Characterization of BAB-TMP, the Babeș Strain of the Fixed Rabies Virus Adapted for Multiplication in Cell Lines
The rabies virus is a major zoonosis that causes severe nervous disease in humans, leading to paralysis and death. The world’s second anti-rabies center was established in 1888 by Victor Babeș, in Bucharest, where an eponymous strain of rabies was isolated and used to develop a method for immunization. The Babeș strain of the rabies virus was used for over 100 years in Romania to produce a rabies vaccine for human use, based on animal nerve tissue, thus having a proven history of prophylactic use. The present study aimed to sequence the whole genome of the Babeș strain and to explore its genetic relationships with other vaccine strains as well as to characterize its relevant molecular traits. After being adapted for multiplication in cell lines and designated BAB-TMP, 99% of the viral genome was sequenced. The overall organization of the genome is similar to that of other rabies vaccine strains. Phylogenetic analysis indicated that the BAB-TMP strain is closely related to the Russian RV-97 vaccine strain, and both seem to have a common ancestor. The nucleoprotein gene of the investigated genome was the most conserved, and the glycoprotein showed several unique amino acid substitutions within the major antigenic sites and linear epitopes.
Open AccessSequencing and Partial Molecular Characterization of BAB-TMP, the Babeș Strain of the Fixed Rabies Virus Adapted for Multiplication in Cell Lines
The rabies virus is a major zoonosis that causes severe nervous disease in humans, leading to paralysis and death. The world’s second anti-rabies center was established in 1888 by Victor Babeș, in Bucharest, where an eponymous strain of rabies was isolated and used to develop a method for immunization. The Babeș strain of the rabies virus was used for over 100 years in Romania to produce a rabies vaccine for human use, based on animal nerve tissue, thus having a proven history of prophylactic use. The present study aimed to sequence the whole genome of the Babeș strain and to explore its genetic relationships with other vaccine strains as well as to characterize its relevant molecular traits. After being adapted for multiplication in cell lines and designated BAB-TMP, 99% of the viral genome was sequenced. The overall organization of the genome is similar to that of other rabies vaccine strains. Phylogenetic analysis indicated that the BAB-TMP strain is closely related to the Russian RV-97 vaccine strain, and both seem to have a common ancestor. The nucleoprotein gene of the investigated genome was the most conserved, and the glycoprotein showed several unique amino acid substitutions within the major antigenic sites and linear epitopes.
- 22 March 2023
- Published by Springer Nature in Archives of Virology
- Vol. 168 (4) , 1-6
Genome characterisation of norovirus GII.P17-GII.17 detected during a large gastroenteritis outbreak in Romania in 2021
Norovirus (NoV) is one of the leading causes of acute gastroenteritis worldwide. Genotype GII.P17-G.II.17 emerged in Asia between 2013 and 2015 and transiently replaced the GII.4 Sydney 2012 variant circulating at that time. We present the genome characterisation of a GII.P17-GII.17 strain causing a large outbreak in Romania in 2021. Our study shows that the 2021 strain belongs to a novel cluster of genotype GII.17, different from the two previously recognised P.17 clusters. Distinctive substitutions in predicted conformational epitopes of VP1 were identified for this new cluster. Also, our phylogenetic analysis showed the existence of another P.17 cluster grouping strains from France and Canada.
- 22 March 2023
- Published by Springer Nature in Archives of Virology
- Vol. 168 (4) , 1-6
Genome characterisation of norovirus GII.P17-GII.17 detected during a large gastroenteritis outbreak in Romania in 2021
Norovirus (NoV) is one of the leading causes of acute gastroenteritis worldwide. Genotype GII.P17-G.II.17 emerged in Asia between 2013 and 2015 and transiently replaced the GII.4 Sydney 2012 variant circulating at that time. We present the genome characterisation of a GII.P17-GII.17 strain causing a large outbreak in Romania in 2021. Our study shows that the 2021 strain belongs to a novel cluster of genotype GII.17, different from the two previously recognised P.17 clusters. Distinctive substitutions in predicted conformational epitopes of VP1 were identified for this new cluster. Also, our phylogenetic analysis showed the existence of another P.17 cluster grouping strains from France and Canada.
- Open Access
- 21 November 2022
- Published by Wiley in Influenza and Other Respiratory Viruses
- Vol. 17 (1) , e13069
Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021–2022 I‐MOVE primary care multicentre study
Background: In 2021–2022, influenza A viruses dominated in Europe. The I‐MOVE primary care network conducted a multicentre test‐negative study to measure influenza vaccine effectiveness (VE).Methods: Primary care practitioners collected information on patients presenting with acute respiratory infection. Cases were influenza A(H3N2) or A(H1N1)pdm09 RT‐PCR positive, and controls were influenza virus negative. We calculated VE using logistic regression, adjusting for study site, age, sex, onset date, and presence of chronic conditions.Results: Between week 40 2021 and week 20 2022, we included over 11 000 patients of whom 253 and 1595 were positive for influenza A(H1N1)pdm09 and A(H3N2), respectively. Overall VE against influenza A(H1N1)pdm09 was 75% (95% CI: 43–89) and 81% (95% CI: 45–93) among those aged 15–64 years. Overall VE against influenza A(H3N2) was 29% (95% CI: 12–42) and 25% (95% CI: −41 to 61), 33% (95% CI: 14–49), and 26% (95% CI: −22 to 55) among those aged 0–14, 15–64, and over 65 years, respectively. The A(H3N2) VE among the influenza vaccination target group was 20% (95% CI: −6 to 39). All 53 sequenced A(H1N1)pdm09 viruses belonged to clade 6B.1A.5a.1. Among 410 sequenced influenza A(H3N2) viruses, all but eight belonged to clade 3C.2a1b.2a.2.Discussion: Despite antigenic mismatch between vaccine and circulating strains for influenza A(H3N2) and A(H1N1)pdm09, 2021–2022 VE estimates against circulating influenza A(H1N1)pdm09 were the highest within the I‐MOVE network since the 2009 influenza pandemic. VE against A(H3N2) was lower than A(H1N1)pdm09, but at least one in five individuals vaccinated against influenza were protected against presentation to primary care with laboratory‐confirmed influenza.
- 21 November 2022
- Published by Wiley in Influenza and Other Respiratory Viruses
- Vol. 17 (1) , e13069
Open AccessInfluenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021–2022 I‐MOVE primary care multicentre study
Background: In 2021–2022, influenza A viruses dominated in Europe. The I‐MOVE primary care network conducted a multicentre test‐negative study to measure influenza vaccine effectiveness (VE).Methods: Primary care practitioners collected information on patients presenting with acute respiratory infection. Cases were influenza A(H3N2) or A(H1N1)pdm09 RT‐PCR positive, and controls were influenza virus negative. We calculated VE using logistic regression, adjusting for study site, age, sex, onset date, and presence of chronic conditions.Results: Between week 40 2021 and week 20 2022, we included over 11 000 patients of whom 253 and 1595 were positive for influenza A(H1N1)pdm09 and A(H3N2), respectively. Overall VE against influenza A(H1N1)pdm09 was 75% (95% CI: 43–89) and 81% (95% CI: 45–93) among those aged 15–64 years. Overall VE against influenza A(H3N2) was 29% (95% CI: 12–42) and 25% (95% CI: −41 to 61), 33% (95% CI: 14–49), and 26% (95% CI: −22 to 55) among those aged 0–14, 15–64, and over 65 years, respectively. The A(H3N2) VE among the influenza vaccination target group was 20% (95% CI: −6 to 39). All 53 sequenced A(H1N1)pdm09 viruses belonged to clade 6B.1A.5a.1. Among 410 sequenced influenza A(H3N2) viruses, all but eight belonged to clade 3C.2a1b.2a.2.Discussion: Despite antigenic mismatch between vaccine and circulating strains for influenza A(H3N2) and A(H1N1)pdm09, 2021–2022 VE estimates against circulating influenza A(H1N1)pdm09 were the highest within the I‐MOVE network since the 2009 influenza pandemic. VE against A(H3N2) was lower than A(H1N1)pdm09, but at least one in five individuals vaccinated against influenza were protected against presentation to primary care with laboratory‐confirmed influenza.
- Open Access
- 30 August 2022
- Published by MDPI AG in Antibiotics
- Vol. 11 (9) , 1171
Characterization of Carbapenemase-Producing Klebsiella pneumoniae Isolates from Two Romanian Hospitals Co-Presenting Resistance and Heteroresistance to Colistin
Klebsiella pneumoniae is a notorious human pathogen involved in healthcare-associated infections. The worldwide expansion of infections induced by colistin-resistant and carbapenemase-producing Enterobacterales (CPE) isolates has been increasingly reported. This study aims to analyze the phenotypic and molecular profiles of 10 colistin-resistant (CR) isolates and 2 pairs of colistin-heteroresistant (ChR) (parental and the corresponding resistant mutants) isolates of K. pneumoniae CPE sourced from two hospitals. The phenotypes of strains in the selected collection had been previously characterized. Antimicrobial susceptibility testing was performed using a Vitek 2 Compact system (BioMérieux SA, Marcy l’Etoile, France), the disc diffusion method, and broth microdilution (BMD) for colistin. Whole-genome sequencing (WGS) did not uncover evidence of any mobile colistin resistance (mcr) genes, although the mgrB gene of seven isolates appeared to be disrupted by insertion sequences (ISKpn25 or ISKpn26). Possible deleterious missense mutations were found in phoP (L4F), phoQ (Q426L, L26Q, L224Q, Q317K), pmrB (R256G, P95L, T157P, V352E), and crrB (P151S) genes. The identified isolates belonged to the following clonal lineages: ST101 (n = 6), ST147 (n = 5), ST258 (n = 2), and ST307 (n = 1). All strains harbored IncF plasmids. OXA-48 producers carried IncL and IncR plasmids, while one blaNDM-1 genome was found to harbor IncC plasmids. Ceftazidime–avibactam remains a therapeutic option for KPC-2 and OXA-48 producers. Resistance to meropenem–vaborbactam has emerged in some blakPC-2-carrying isolates. Our study demonstrates that the results of WGS can provide essential evidence for the surveillance of antimicrobial resistance.
- 30 August 2022
- Published by MDPI AG in Antibiotics
- Vol. 11 (9) , 1171
Open AccessCharacterization of Carbapenemase-Producing Klebsiella pneumoniae Isolates from Two Romanian Hospitals Co-Presenting Resistance and Heteroresistance to Colistin
Klebsiella pneumoniae is a notorious human pathogen involved in healthcare-associated infections. The worldwide expansion of infections induced by colistin-resistant and carbapenemase-producing Enterobacterales (CPE) isolates has been increasingly reported. This study aims to analyze the phenotypic and molecular profiles of 10 colistin-resistant (CR) isolates and 2 pairs of colistin-heteroresistant (ChR) (parental and the corresponding resistant mutants) isolates of K. pneumoniae CPE sourced from two hospitals. The phenotypes of strains in the selected collection had been previously characterized. Antimicrobial susceptibility testing was performed using a Vitek 2 Compact system (BioMérieux SA, Marcy l’Etoile, France), the disc diffusion method, and broth microdilution (BMD) for colistin. Whole-genome sequencing (WGS) did not uncover evidence of any mobile colistin resistance (mcr) genes, although the mgrB gene of seven isolates appeared to be disrupted by insertion sequences (ISKpn25 or ISKpn26). Possible deleterious missense mutations were found in phoP (L4F), phoQ (Q426L, L26Q, L224Q, Q317K), pmrB (R256G, P95L, T157P, V352E), and crrB (P151S) genes. The identified isolates belonged to the following clonal lineages: ST101 (n = 6), ST147 (n = 5), ST258 (n = 2), and ST307 (n = 1). All strains harbored IncF plasmids. OXA-48 producers carried IncL and IncR plasmids, while one blaNDM-1 genome was found to harbor IncC plasmids. Ceftazidime–avibactam remains a therapeutic option for KPC-2 and OXA-48 producers. Resistance to meropenem–vaborbactam has emerged in some blakPC-2-carrying isolates. Our study demonstrates that the results of WGS can provide essential evidence for the surveillance of antimicrobial resistance.